Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Identification of a serum biomarker signature associated with metastatic prostate cancer.
Proteomics Clin Appl. 2021 May;15(2-3):e2000025. doi: 10.1002/prca.202000025. Epub 2021 May 4.
Proteomics Clin Appl. 2021.
PMID: 33580906
Free PMC article.
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma.
Lokhande L, Kuci Emruli V, Eskelund CW, Kolstad A, Hutchings M, Räty R, Niemann CU, Grønbaek K, Jerkeman M, Ek S.
Lokhande L, et al. Among authors: kuci emruli v.
Cancer Rep (Hoboken). 2022 Jul;5(7):e1524. doi: 10.1002/cnr2.1524. Epub 2021 Jul 28.
Cancer Rep (Hoboken). 2022.
PMID: 34319003
Free PMC article.
Item in Clipboard
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.
Lokhande L, Kuci Emruli V, Kolstad A, Hutchings M, Räty R, Jerkeman M, Ek S.
Lokhande L, et al. Among authors: kuci emruli v.
BMC Cancer. 2020 Dec 7;20(1):1202. doi: 10.1186/s12885-020-07678-4.
BMC Cancer. 2020.
PMID: 33287742
Free PMC article.
Item in Clipboard
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou N, Ntoufa S, Tsagiopoulou M, Moysiadis T, Bhoi S, Malousi A, Psomopoulos F, Mansouri L, Laidou S, Papazoglou D, Gounari M, Pasentsis K, Plevova K, Kuci-Emruli V, Duran-Ferrer M, Davis Z, Ek S, Rossi D, Gaidano G, Ritgen M, Oscier D, Stavroyianni N, Pospisilova S, Davi F, Ghia P, Hadzidimitriou A, Belessi C, Martin-Subero JI, Pott C, Rosenquist R, Stamatopoulos K.
Papakonstantinou N, et al. Among authors: kuci emruli v.
Int J Cancer. 2019 Jun 1;144(11):2695-2706. doi: 10.1002/ijc.31999. Epub 2019 Jan 15.
Int J Cancer. 2019.
PMID: 30447004
Free article.
Item in Clipboard
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
Freiburghaus C, Emruli VK, Johansson A, Eskelund CW, Grønbæk K, Olsson R, Ek F, Jerkeman M, Ek S.
Freiburghaus C, et al. Among authors: emruli vk.
BMC Cancer. 2018 Apr 25;18(1):466. doi: 10.1186/s12885-018-4346-1.
BMC Cancer. 2018.
PMID: 29695239
Free PMC article.
Item in Clipboard
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
Emruli VK, Olsson R, Ek F, Ek S.
Emruli VK, et al.
BMC Cancer. 2016 Jul 18;16:493. doi: 10.1186/s12885-016-2550-4.
BMC Cancer. 2016.
PMID: 27430213
Free PMC article.
Item in Clipboard
Cite
Cite